NASDAQ:BLRX

BioLineRx - BLRX Earnings Date, Estimates & Call Transcripts

$0.62

-0.01 (-1.59%)

(As of 02/6/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.60
▼
$0.63
50-Day Range: $0.57
▼
$0.74
52-Week Range: $0.55
▼
$1.98

Volume: 273,635 shs
Average Volume: 268,827 shs
Market Capitalization: $37.99 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.00

Institutional Ownership

Upcoming Earnings Date: Mar. 15Estimated
Actual EPS (Nov. 15): -$0.15 Beat By $0.01
Consensus EPS (Nov. 15): -$0.16
Last Year's Q4 EPS (11/18/2021): -$0.23

Earnings Per Share Revenue

BLRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BLRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioLineRx Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	1	($0.12)	($0.12)	($0.12)
Q2 2023	1	($0.12)	($0.12)	($0.12)
Q3 2023	1	($0.14)	($0.14)	($0.14)
Q4 2023	1	($0.12)	($0.12)	($0.12)
FY 2023	4	($0.50)	($0.50)	($0.50)

BLRX Earnings Date and Information

BioLineRx last announced its earnings data on November 15th, 2022. The biotechnology company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.01. BioLineRx has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for BioLineRx are expected to grow in the coming year, from ($0.54) to ($0.48) per share. BioLineRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 15th, 2023 based off prior year's report dates.

BioLineRx Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate
3/15/2023 (Estimated)
11/15/2022	Q3 2022	($0.16)	($0.15)	+$0.01	($0.15)
8/16/2022	Q2 2022	($0.14)	($0.16)	($0.02)	($0.16)
5/11/2022	Q1 2022	($0.15)	($0.10)	+$0.05	($0.10)
3/16/2022	Q4 2021	($0.14)	($0.08)	+$0.06	($0.08)
12/8/2021	Q3	($0.16)	($0.15)	+$0.01
11/18/2021	Q3 2021	($0.13)	($0.23)	($0.10)	($0.23)

8/18/2021	Q2	($0.12)	($0.15)	($0.03)	($0.15)
5/26/2021	Q1 2021	($0.15)	($0.27)	($0.12)	($0.27)
2/23/2021	Q4 2020	($0.25)	($0.61)	($0.36)	($0.61)
11/23/2020	9/30/2020	($0.36)	($0.30)	+$0.06	($0.30)
8/6/2020	Q2 2020	($0.60)	($0.45)	+$0.15	($0.45)
5/20/2020	Q1 2020	($0.83)	($0.60)	+$0.23	($0.60)
3/12/2020	Q4 2019	($0.64)	($0.97)	($0.33)	($0.97)
11/11/2019	Q3 2019	($0.67)	($0.40)	+$0.27	($0.40)
8/6/2019	Q2	($0.65)	($0.04)	+$0.61	($0.04)
5/14/2019	3/31/2019	($0.05)	($0.05)		($0.05)
3/28/2019	12/31/2018	($0.09)	($0.05)	+$0.04	($0.05)
11/8/2018	9/30/2018	($0.06)	($0.06)		($0.06)
8/13/2018	Q2 2018	($0.06)	($0.05)	+$0.01	($0.05)
5/22/2018	3/31/2018	($0.07)	($0.06)	+$0.01	($0.06)
3/6/2018	Q4 2017	($0.06)	($0.07)	($0.01)	($0.07)
11/21/2017	Q3 2017	($0.05)	($0.07)	($0.02)	($0.07)
8/8/2017	6/30/2017	($0.05)	($0.05)		($0.05)	$0.01 million
5/25/2017	3/31/2017	($0.05)	($0.08)	($0.03)	($0.08)	$0.01 million
3/23/2017	12/31/2016	($0.08)	($0.13)	($0.05)	($0.13)	$0.02 million
11/22/2016	Q316	($0.07)	($0.08)	($0.01)	($0.08)
8/11/2016	Q216	($0.07)	($0.07)		($0.07)
5/17/2016	Q116	($0.08)	($0.10)	($0.02)	($0.10)
3/10/2016	Q415	($0.06)	($0.07)	($0.01)	($0.07)
11/16/2015	Q315	($0.08)	($0.03)	+$0.05	($0.03)
8/20/2015	Q215	($0.10)	($0.09)	+$0.01	($0.09)
5/18/2015	Q115	($0.10)	($0.08)	+$0.02	($0.08)
4/13/2015	Q4 2014	($0.10)	($0.11)	($0.01)	($0.11)
11/10/2014	Q314	($0.11)	($0.02)	+$0.09	($0.02)
8/6/2014	Q214	($0.09)	($0.12)	($0.03)	($0.12)
5/20/2014	Q114	($0.11)	($0.01)	+$0.10	($0.10)
3/17/2014	Q4 2013	($0.18)	($0.20)	($0.02)	($0.20)
11/13/2013	Q3 2013	($0.18)	($0.20)	($0.02)	($0.20)
8/6/2013	Q2 2013	($0.15)	($0.20)	($0.05)	($0.20)
5/7/2013	Q1 2013	($0.02)	($0.20)	($0.18)	($0.20)

3/12/2013	Q4 2012	($0.29)	($0.30)	($0.01)	($0.30)
11/14/2012	Q312		($0.15)	($0.15)
8/15/2012	Q2 2012	($0.25)	($0.02)	+$0.23	($0.02)
5/15/2012	Q1 2012		($0.30)	($0.30)	($0.30)
3/22/2012	Q4 2011		($0.30)	($0.30)	($0.30)
11/29/2011	Q3 2011		($0.20)	($0.20)	($0.20)
8/23/2011	Q2 2011		($0.40)	($0.40)	($0.40)

BioLineRx Earnings - Frequently Asked Questions

When is BioLineRx's earnings date?: BioLineRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 15th, 2023 based off last year's report dates. Learn more on BLRX's earnings history.
Did BioLineRx beat their earnings estimates last quarter?: In the previous quarter, BioLineRx (NASDAQ:BLRX) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.01. Learn more on analysts' earnings estimate vs. BLRX's actual earnings.

How much profit does BioLineRx generate each year?: BioLineRx (NASDAQ:BLRX) has a recorded net income of -$27.05 million. BLRX has generated -$0.49 earnings per share over the last four quarters.
What is BioLineRx's EPS forecast for next year?: BioLineRx's earnings are expected to grow from ($0.54) per share to ($0.48) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

CME Group (2/8/2023)
O'Reilly Automotive (2/8/2023)
Uber Technologies (2/8/2023)
Dominion Energy (2/8/2023)
Southern Copper (2/8/2023)
CVS Health (2/8/2023)
Emerson Electric (2/8/2023)
Walt Disney (2/8/2023)
Eaton (2/8/2023)
PayPal (2/9/2023)

This page (NASDAQ:BLRX) was last updated on 2/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BioLineRx - BLRX Earnings Date, Estimates & Call Transcripts

BLRX Earnings Estimates and Actuals by Quarter

BLRX Estimated and Actual Revenue by Quarter

BioLineRx Analyst Forecasts

BLRX Earnings Date and Information

BioLineRx Earnings History by Quarter

BioLineRx Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

BioLineRx - BLRX Earnings Date, Estimates & Call Transcripts

Earnings Summary

BLRX Earnings Estimates and Actuals by Quarter

BLRX Estimated and Actual Revenue by Quarter

BioLineRx Analyst Forecasts

BLRX Earnings Date and Information

BioLineRx Earnings History by Quarter

BioLineRx Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat